SonoScape Medical Corp.

Total Valuation

SonoScape Medical Corp. carries a market capitalization of 8.12B, placing it among publicly traded companies globally. Its enterprise value stands at 11.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

SonoScape Medical Corp. currently has 432.71M shares outstanding.

Valuation Ratios

SonoScape Medical Corp. trades at a trailing price-to-earnings ratio of 680.64. The price-to-sales ratio is 6.53, and the price-to-book ratio stands at 6.94.

Enterprise Valuation

On an enterprise value basis, SonoScape Medical Corp. trades at an EV/EBITDA multiple of 323.91 and an EV/FCF ratio of 73.48. The EV/Sales ratio of 5.90 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 323.91 provides insight into valuation relative to core operating earnings.

Financial Position

SonoScape Medical Corp. maintains a current ratio of 3.30, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.60, indicating elevated leverage, while an interest coverage ratio of 5.58 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

SonoScape Medical Corp.'s stock has declined approximately -32.86517% over the past 52 weeks. The 50-day moving average sits at 21.29, while the 200-day moving average is 26.46.

Income Statement

Over the trailing twelve months, SonoScape Medical Corp. generated 1.97B in revenue and converted that into 18.85M in net income, yielding earnings per share of 0.04. EBITDA reached 35.78M, while operating income came in at 35.78M.

Balance Sheet

SonoScape Medical Corp. holds 1.51B in cash and equivalents against 268.04M in total debt, resulting in a net debt position of -1.29B. Total book value stands at 1.85B, with working capital of 1.82B providing operational flexibility.

Cash Flow

After subtracting -163.28M in capital expenditures, free cash flow totaled -163.28M - equivalent to -0.38 per share.

Margins

SonoScape Medical Corp. operates with a gross margin of 61.07, reflecting its pricing power and cost economics. The operating margin of 1.82 and net profit margin of 0.96 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 263.76 indicates the proportion of earnings distributed to shareholders.

Scores

SonoScape Medical Corp. posts an Altman Z-Score of 10.20, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.